1. Home
  2. PRCH vs MPLT Comparison

PRCH vs MPLT Comparison

Compare PRCH & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

N/A

Current Price

$17.06

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$11.33

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRCH
MPLT
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
PRCH
MPLT
Price
$17.06
$11.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$18.63
$32.67
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
04-28-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
82.39
EPS
0.01
N/A
Revenue
$482,414,000.00
N/A
Revenue This Year
$4.15
N/A
Revenue Next Year
$17.05
N/A
P/E Ratio
$1,709.00
N/A
Revenue Growth
10.18
N/A
52 Week Low
$6.36
$9.10
52 Week High
$19.44
$40.43

Technical Indicators

Market Signals
Indicator
PRCH
MPLT
Relative Strength Index (RSI) 65.65 30.32
Support Level $9.08 $10.83
Resistance Level N/A $20.20
Average True Range (ATR) 0.73 0.96
MACD 0.05 0.59
Stochastic Oscillator 83.97 25.08

Price Performance

Historical Comparison
PRCH
MPLT

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: